Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

BUY
$218.29 - $256.91 $654 - $770
3 Added 0.29%
1,044 $266,000
Q3 2022

Nov 10, 2022

SELL
$51.03 - $264.23 $86,853 - $449,719
-1,702 Reduced 62.05%
1,041 $232,000
Q2 2022

Aug 10, 2022

SELL
$234.74 - $275.42 $1,173 - $1,377
-5 Reduced 0.18%
2,743 $676,000
Q1 2022

May 16, 2022

BUY
$243.64 - $270.48 $243 - $270
1 Added 0.04%
2,748 $731,000
Q4 2021

Feb 14, 2022

SELL
$230.08 - $250.94 $8,743 - $9,535
-38 Reduced 1.36%
2,747 $691,000
Q3 2021

Nov 12, 2021

BUY
$232.72 - $256.47 $17,221 - $18,978
74 Added 2.73%
2,785 $684,000
Q2 2021

Aug 13, 2021

SELL
$232.65 - $254.58 $5,118 - $5,600
-22 Reduced 0.8%
2,711 $659,000
Q1 2021

May 17, 2021

SELL
$232.09 - $256.88 $9,515 - $10,532
-41 Reduced 1.48%
2,733 $664,000
Q4 2020

Feb 17, 2021

BUY
$221.92 - $245.94 $615,606 - $682,237
2,774 New
2,774 $694,000

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.2B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track S&T Bank Portfolio

Follow S&T Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of S&T Bank, based on Form 13F filings with the SEC.

News

Stay updated on S&T Bank with notifications on news.